Victims of the deadly fungal meningitis outbreak traced to a Framingham pharmacy aren’t likely to collect much money from the company’s insurance policies, a lawyer for the bankrupt firm said at a creditors meeting in Boston Wednesday.

Daniel Cohn, a Boston attorney representing the New England Compounding Center, said he was reluctant to estimate how much the company hopes to receive from the policies to pay victims because the issue is complex and subject to negotiation. But he said personal injury lawyers who have reviewed the policies “were very disappointed.”